Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 13 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Novan, Inc. | 2,598,485 | reported | 02 Jul 2019 | tx 3−25,000 |
| Poseida Therapeutics, Inc. | 0 | reported | 08 Jan 2025 | tx 14+2,647,548−11,835,673 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Jan 2025 | TENDER | Poseida Therapeutics, Inc. | 11,835,673 | — | |
| 08 Aug 2022 | PURCHASE | Poseida Therapeutics, Inc. | 2,150,000 | 3.50 USD | anomaly |
| 06 Dec 2021 | PURCHASE | Poseida Therapeutics, Inc. | 1,828 | 6.90 USD | |
| 30 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 28,592 | 6.85 USD | |
| 02 Dec 2021 | PURCHASE | Poseida Therapeutics, Inc. | 4,296 | 6.88 USD | |
| 01 Dec 2021 | PURCHASE | Poseida Therapeutics, Inc. | 18,365 | 6.85 USD | |
| 29 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 11,057 | 6.89 USD | |
| 26 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 27,251 | 6.81 USD | |
| 24 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 1,054 | 6.89 USD | anomaly |
| 23 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 14,625 | 6.77 USD | |
| 19 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 11,104 | 7.44 USD | |
| 17 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 280,384 | 7.21 USD | anomaly |
| 18 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 71,312 | 7.18 USD | |
| 16 Nov 2021 | PURCHASE | Poseida Therapeutics, Inc. | 27,680 | 7.17 USD | |
| 01 Jul 2019 | SALE | Novan, Inc. | 913 | 2.74 USD | |
| 28 Jun 2019 | SALE | Novan, Inc. | 17,800 | 2.69 USD | |
| 02 Jul 2019 | SALE | Novan, Inc. | 6,287 | 2.75 USD |